CompletedNCT00812461
Nalmefene and relapse outcomes in alcohol dependence
About this title
Read the official source — NCT00812461Researchers compared Nalmefene and placebo to find out how the approaches affected alcohol use in people with alcohol dependence.
Medication studyAges 18+Multiple countriesMental health
Understand this study
What did researchers investigate?
Researchers compared Nalmefene and placebo to find out how the approaches affected alcohol use in people with alcohol dependence.
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Assebroek and 56 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 678
- Sponsor
- H. Lundbeck A/S
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France, Belgium, Czechia, ...
- Age range
- Over 18 Years
- Official registry ID
- NCT00812461
- Official title
Show the full official title
Nalmefene Efficacy Study II: Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, as Needed Use, in Patients With Alcohol Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedAssebroek, Belgium · Bruges, Belgium · Charleroi, Belgium
45 more locations
- Kortenberg, Belgium
- Liège, Belgium
- Mechelen, Belgium
- Ostend, Belgium
- Litoměřice, Czechia
- Prague, Czechia
- Angers, France
- Bully-les-Mines, France
- Clichy, France
- Élancourt, France
- La Rochelle, France
- Le Pecq, France
- Lille, France
- Lyon, France
- Nancy, France
- Nîmes, France
- Rennes, France
- Sartrouville, France
- Strasbourg, France
- Toulouse, France
- Villejuif, France
- Bologna, Italy
- Cento, Italy
- Florence, Italy
- Parma, Italy
- Rome, Italy
- Soverato Marina, Italy
- Gdansk, Poland
- Leszno, Poland
- Lublin, Poland
- Piekary Śląskie, Poland
- Skorzewo, Poland
- Szczecin, Poland
- Angra do Heroísmo, Portugal
- Lisbon, Portugal
- Mem Martins, Portugal
- Alicante, Spain
- Barcelona, Spain
- Burgos, Spain
- Madrid, Spain
- Mallorca, Spain
- Oviedo, Spain
- Valencia, Spain
- Zamora, Spain
- Czechia
Questions about this study
What did researchers investigate?
Researchers compared Nalmefene and placebo to find out how the approaches affected alcohol use in people with alcohol dependence.
Who is behind this study?
The study sponsor is H. Lundbeck A/S.
Did this study involve medication?
Yes. The study involved medication, including Placebo and Nalmefene.
Who was this study for?
Listed age limits: from 18 years.
Want to explore more studies?
Explore studiesRelated studies
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
A Phase II/III, multi-center, open-label, extension study to determine the long-term safety, tolerability, and efficacy of evenamide in patients with psychiatric disorders who participated in a pre...